Plain-English translation of NCT06930729 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a smartphone app called Moodivate can help treat depression in people who have survived cancer. About half of participants will use the Moodivate app on their phone daily to track their mood and schedule activities that matter to them, while the other half will receive traditional one-on-one mental health counseling. The study wants to see if the app works as well as standard care, while being easier to access for people in rural areas or those with transportation challenges.
Depression affects nearly one in four cancer survivors, but many don't have access to mental health treatment because of distance, lack of providers, or other barriers—especially in rural areas. This trial exists to see if a digital app could provide effective depression treatment without requiring people to travel to appointments or face long waiting lists.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be randomly assigned to either use the Moodivate app or receive standard mental health therapy. If you get the app, you'll download it and use it at least once daily—it helps you identify what matters to you, plan activities, and track your mood. Either way, you'll fill out brief surveys about how you're doing at 12, 16, 20, and 24 weeks. The whole study lasts about 6 months, and you can do everything from home.
AI-generated summary from trial data · Aug 12, 2026 · Not medical advice
United States